Regulatory Approval Drives iRhythm Technologies (IRTC) Stock Upward
Following a crucial regulatory approval, iRhythm Technologies, Inc. (NASDAQ: IRTC) saw a notable increase in stock performance. After receiving approval from the U.S. Food and Drug Administration (FDA) for recent changes to its Zio AT device, IRTC shares increased 18.36% to $73.50. This is a critical turning point in the business’s continuous attempts to improve […]
Regulatory Approval Drives iRhythm Technologies (IRTC) Stock Upward Read More »